Growth Metrics

Immunocore Holdings (IMCR) Consolidated Net Income (2023 - 2025)

Historic Consolidated Net Income for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to -$196000.0.

  • Immunocore Holdings' Consolidated Net Income fell 10224.36% to -$196000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.3 million, marking a year-over-year increase of 3783.2%. This contributed to the annual value of -$51.1 million for FY2024, which is 759.67% up from last year.
  • Latest data reveals that Immunocore Holdings reported Consolidated Net Income of -$196000.0 as of Q3 2025, which was down 10224.36% from -$10.3 million recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Consolidated Net Income ranged from a high of $8.7 million in Q3 2024 and a low of -$52.6 million during Q4 2021
  • For the 5-year period, Immunocore Holdings' Consolidated Net Income averaged around -$17.6 million, with its median value being -$17.2 million (2022).
  • Its Consolidated Net Income has fluctuated over the past 5 years, first skyrocketed by 86423.84% in 2024, then plummeted by 10224.36% in 2025.
  • Quarter analysis of 5 years shows Immunocore Holdings' Consolidated Net Income stood at -$52.6 million in 2021, then surged by 66.87% to -$17.4 million in 2022, then dropped by 13.24% to -$19.7 million in 2023, then decreased by 20.48% to -$23.8 million in 2024, then surged by 99.18% to -$196000.0 in 2025.
  • Its Consolidated Net Income was -$196000.0 in Q3 2025, compared to -$10.3 million in Q2 2025 and $5.0 million in Q1 2025.